Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  itraconazole
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-17 of 17 for your search:
Start Over
Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation
Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 15 and under
Sponsor: Other
Protocol IDs: 2006-02-069, NCT00336531
The Relationship of Defeverscence and Itraconazole Plasma Level Study in Immunocompromised Participants
Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 20 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR016597, ITR-KOR-5085, ITRFUN4049, NCT01021683
Observational Study Investigating the Response Rate of Itraconazole Injection in Treating Immunocompromised Patients
Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR015691, NCT01060462
Efficacy of Itraconazole as Secondary Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplantation or Chemotherapy With Prior Invasive Fungal Infection
Phase: Phase IV
Type: Supportive care
Status: Completed
Age: 18 to 65
Sponsor: Other
Protocol IDs: SpoIV-CHA-IIS-0802, ITRFUN4044, NCT01198236
Prophylaxis Trial of Posaconazole Versus Standard Azole Therapy for Neutropenic Patients (Study P01899)
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 13 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: P01899, NCT00044486
A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and Those With Febrile Neutropenia Suspected of Fungal Infection
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 18 to 79
Sponsor: Pharmaceutical / Industry
Protocol IDs: CR014299, JK1211-JPN-07, NCT00784368
Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation
Phase: Phase III
Type: Supportive care
Status: Completed
Age: 13 and over
Sponsor: NCI, Other
Protocol IDs: 1322.00, FHCRC-1322.00, NCI-H99-0030, CDR0000067050, NCT00003883
Phase I/II Study of PKC412 With or Without Itraconazole in Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Pharmaceutical / Industry
Protocol IDs: MSKCC-02021, NOVARTIS-CPKC412A2104, NCI-G02-2107, UCLA-0305058-01, NCT00045578
A Two-dose Level Clinical Trial of Itraconazole in Patients With Metastatic Prostate Cancer Who Have Had Disease Progression While on Hormonal Therapy
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: J0932, JHMI-IRB number: NA_00027099, NCT00887458
Pilot Biomarker Trial to Evaluate the Efficacy of Itraconazole in Patients w/ Basal Cell Carcinomas
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Temporarily closed
Age: 18 and over
Sponsor: Other
Protocol IDs: SKIN0004, SU-04162010-5722, NCT01108094
Micafungin Versus Intravenous Itraconazole as Empirical Antifungal Therapy for Febrile Neutropenic Patients With Hematological Diseases
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 to 65
Sponsor: Other
Protocol IDs: 4-2011-0794, NCT01344681
Investigation of Potential Drug-drug Interaction of Volasertib With Itraconazole in Patients With Various Tumours
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 to 70
Sponsor: Pharmaceutical / Industry
Protocol IDs: 1230.24, 2011-002367-23, NCT01772563
To Assess the Effect of Itraconazole (a CYP3A4 Inhibitor) on the Pharmacokinetics of Olaparib, and the Effect of Olaparib on QT Interval Following Oral Dosing of a Tablet Formulation to Patients With Advanced Solid Tumours
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: D0816C00007, 2013-001892-18, NCT01900028
To Assess the Effect of Itraconazole and Fluconazole on the Pharmacokinetics of Selumetinib in Healthy Male Volunteers
Phase: Phase I
Type: Biomarker/Laboratory analysis
Status: Completed
Age: 18 to 45
Sponsor: Pharmaceutical / Industry
Protocol IDs: D1532C00083, NCT02093728
Voriconazole Compared With Itraconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Phase: No phase specified
Type: Supportive care
Status: Completed
Age: 12 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000355116, P30CA016042, UCLA-0307071, NCT00079222
A Pilot Trial of Itraconazole Pharmacokinetics in Patients With Metastatic Breast Cancer
Phase: No phase specified
Type: Treatment
Status: Closed
Age: 18 and over
Sponsor: Other
Protocol IDs: 0809-10; IUCRO-0239, NCT00798135
Start Over